Image

Violet Light for the Suppression of Myopia

Violet Light for the Suppression of Myopia

Recruiting
5-12 years
All
Phase N/A

Powered by AI

Overview

The study explores the suppression of myopia via violet light.

Description

The study uses violet light-emitting lamps as the variable and regular, white light lamps as the control in assessing whether violet light, especially during over periods of dawn and dusk could help suppress the progression of myopia in developing children.

Eligibility

Inclusion Criteria:

  • Children must be between 5 to <13 years old.
  • Diagnosis of Myopia (ICD-10-CM Diagnosis

Code H52.13) with refractive error:

  1. Myopia -1.00D to -6.00D spherical equivalent (SE) in both eyes
  2. Astigmatism <=1.50D in both eyes
  3. Anisometropia <=1.00D SE • Relocation outside of the CCHMC area within the next 12 months is not anticipated.

Exclusion Criteria:

        Current or previous myopia treatment with atropine, pirenzepine, or other antimuscarinic
        agents
          -  Current or previous use of bifocals, progressive addition lenses, or multi-focal
             contact lenses
          -  Current or previous use of orthoK, rigid gas permeable, or other contact lenses being
             used to reduce myopia progression
          -  Current or prior history of manifest strabismus, amblyopia, or nystagmus
          -  Abnormality of cornea, lens, central retina, iris, or ciliary body
          -  Prior eyelid, strabismus, intraocular, or refractive surgery
          -  Down syndrome or cerebral palsy

Study details
    Myopia
    Phototherapy

NCT06110520

Children's Hospital Medical Center, Cincinnati

25 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.